ストックスクリーナーアプリを入手
0.9436
5.64%
-0.0564
アフターアワーズ：
.95
0.0064
+0.68%
前日終値:
$1.00
開ける：
$1.02
24時間の取引高:
143.50K
Relative Volume:
1.28
時価総額：
$59.08M
収益：
$33.79M
当期純損益:
$-18.67M
株価収益率:
-2.6343
EPS:
-0.3582
ネットキャッシュフロー:
$-19.17M
1週間 パフォーマンス:
-8.39%
1か月 パフォーマンス:
-21.37%
6か月 パフォーマンス:
-9.27%
1年 パフォーマンス:
-8.39%
1日の値動き範囲:
$0.9435
$1.04
1週間の範囲:
$0.9435
$1.08
52週間の値動き範囲:
$0.7101
$1.61
Cytosorbents Corp Stock (CTSO) Company Profile
CTSO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CTSO
Cytosorbents Corp
|
0.9436 | 62.61M | 33.79M | -18.67M | -19.17M | -0.3582 |
|
ABT
Abbott Laboratories
|
126.54 | 218.59B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.14 | 157.13B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
403.53 | 151.59B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
92.94 | 118.29B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
80.00 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Cytosorbents Corp Stock (CTSO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-09-07 | 開始されました | B. Riley Securities | Buy |
| 2021-10-14 | 再開されました | B. Riley Securities | Buy |
| 2020-09-17 | 開始されました | Jefferies | Buy |
| 2020-09-01 | 開始されました | SVB Leerink | Outperform |
| 2017-08-08 | 繰り返されました | Maxim Group | Buy |
| 2016-10-26 | 開始されました | Aegis Capital | Buy |
| 2016-05-24 | 開始されました | Maxim Group | Buy |
| 2015-10-29 | アップグレード | WBB Securities | Speculative Buy → Buy |
| 2015-05-12 | 繰り返されました | MLV & Co | Buy |
| 2015-04-01 | 繰り返されました | MLV & Co | Buy |
| 2015-03-05 | 開始されました | MLV & Co | Buy |
| 2015-02-25 | 開始されました | WBB Securities | Speculative Buy |
| 2015-01-27 | 繰り返されました | H.C. Wainwright | Buy |
すべてを表示
Cytosorbents Corp (CTSO) 最新ニュース
Is Cytosorbents Corporation stock a good hedge against inflationAccelerated financial growth - jammulinksnews.com
What analysts say about Cytosorbents Corporation stockUnmatched market performance - jammulinksnews.com
What drives Cytosorbents Corporation stock priceStrongest growth potential - jammulinksnews.com
Why Cytosorbents Corporation stock attracts strong analyst attentionBreakout Momentum Stocks - Newser
Cytosorbents (NASDAQ:CTSO) Given “Buy” Rating at D. Boral Capital - Defense World
CytoSorbents (CTSO) Stock Rating and Price Target Maintained by - GuruFocus
Is Cytosorbents Corporation a good long term investmentExtraordinary profit generation - jammulinksnews.com
What institutions are buying Cytosorbents Corporation stock nowLong Term Low Risk Growth - Newser
What makes Cytosorbents Corporation stock price move sharplyRisk Controlled Trading Ideas - Newser
Cytosorbents stock plunges after regulatory setbacks for key device - Investing.com
CytoSorbents provides FDA, Health Canada regulatory update for DrugSorb-ATR - TipRanks
Cytosorbents Provides U.S. FDA And Health Canada Regulatory Update For Drugsorb-Atr - TradingView
CytoSorbents receives FDA appeal hearing date for DrugSorb-ATR device - Investing.com
CytoSorbents Provides U.S. FDA and Health Canada Regulatory Update for DrugSorb-ATR - PR Newswire
Cytosorbents Corporation(NasdaqCM: CTSO) added to Russell Microcap Index - MarketScreener
CytoSorbents files appeal with FDA over denied device application - Investing.com
CytoSorbents Q1 2025 slides: Revenue dips 3% as company targets breakeven by year-end - Investing.com
Millennium Management LLC Buys Shares of 33,280 Cytosorbents Co. (NASDAQ:CTSO) - Defense World
Cytosorbents announces voting results from annual meeting By Investing.com - Investing.com Canada
Cytosorbents announces voting results from annual meeting - Investing.com
CytoSorbents Warrants Expire Worthless as Stock Price Fails Threshold - Investing.com
Cytosorbents Co. (NASDAQ:CTSO) Shares Purchased by Northern Trust Corp - Defense World
Critical Care Leader CytoSorbents Reveals Growth Strategy at Jefferies Healthcare Conference - Stock Titan
Cytosorbents Therapy Significantly Reduces Bleeding in Urgent CABG Patients on Ticagrelor in New Data Presented At EuroPCR 2025 - marketscreener.com
CytoSorbents device cuts bleeding in CABG patients - Investing.com
New Clinical Data: How CytoSorbents' Breakthrough Device Slashes Severe Bleeding Risk in Urgent Heart Surgery - Stock Titan
Cytosorbents (NASDAQ:CTSO) Coverage Initiated by Analysts at StockNews.com - Defense World
Cytosorbents FY2025 EPS Forecast Lifted by HC Wainwright - Defense World
D. Boral Capital Reiterates “Buy” Rating for Cytosorbents (NASDAQ:CTSO) - Defense World
Cytosorbents (NASDAQ:CTSO) Earns Neutral Rating from HC Wainwright - Defense World
Cytosorbents Corporation (NASDAQ:CTSO) Q1 2025 Earnings Call Transcript - Insider Monkey
Cytosorbents Corp’s Earnings Call: A Balanced Outlook - TipRanks
CytoSorbents (CTSO) Receives Neutral Rating from HC Wainwright & Co. | CTSO Stock News - GuruFocus
CytoSorbents (CTSO) Maintains Buy Rating with $10 Price Target | - GuruFocus
CytoSorbents (CTSO) Maintains Buy Rating with $10 Price Target | CTSO Stock News - GuruFocus
CytoSorbents: Q1 Earnings Snapshot - CT Insider
CytoSorbents Corp (CTSO) Q1 2025 Earnings Call Highlights: Navigating Challenges and ... - Yahoo Finance
CytoSorbents Corp (CTSO) Q1 2025 Earnings Call Highlights: Navigating Challenges and Strengthening Financials - GuruFocus
StockNews.com Initiates Coverage on Cytosorbents (NASDAQ:CTSO) - Defense World
CytoSorbents (CTSO) Targets Growth Amid Regulatory Challenges - GuruFocus
Cytosorbents Corp (CTSO) 財務データ
収益
当期純利益
現金流量
EPS
1.27%
大文字化:
|
ボリューム (24 時間):